Courtney A Cullis

USPTO Granted Patents = 15 (Patent Applications = 7)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 11.5

ph-index = 5

Forward Citations = 77(Granted Patents)

Location History:

Belmont, MA (US) (2005)
Bedford, MA (US) (2008 - 2020)
Cambridge, MA (US) (2023 - 2024)

Company Filing History:

10 out of 850

Millennium Pharmaceuticals Limited

patents

2 out of 1,179

Takeda Pharmaceutical Company Limited

patents

2 out of 1,210

Dana-farber-cancer Institute Inc.

patents

4. 1 out of 4,179

Abbott Laboratories Corporation

patents

Years Active: 2005-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391671 - Allosteric EGFR inhibitors and methods of use thereof (2025-08-19),

2. 12377080 - Allosteric EGFR inhibitors and methods of use thereof (2025-08-05),

3. 12054512 - Sting modulator compounds, and methods of making and using (2024-08-06),

4. 11542293 - Sting modulator compounds, and methods of making and using (2023-01-03),

5. 10538533 - Heteroaryls and uses thereof (2020-01-21),

6. 10202373 - Heteroaryls and uses thereof (2019-02-12),

7. 9802960 - Heteroaryls and uses thereof (2017-10-31),

8. 9751854 - Heteroaryls and uses thereof (2017-09-05),

9. 8901136 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes (2014-12-02),

10. 8859768 - Heteroaryls and uses thereof (2014-10-14),

11. 8481550 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes (2013-07-09),

12. 8008307 - Heteroaryl compounds useful as inhibitors of E1 activating enzymes (2011-08-30),

13. 7935694 - Lactam compounds useful as protein kinase inhibitors (2011-05-03),

14. 7459448 - Lactam compounds useful as protein kinase inhibitors (2008-12-02),

15. 6921821 - Antagonists of melanin concentrating hormone receptor (2005-07-26),

Title: The Visionary Innovations of Inventor Courtney A Cullis

Introduction

Courtney A Cullis, a pioneering inventor based in Bedford, MA, stands as a shining example of a visionary individual whose dedication to innovation continues to inspire the next generation of inventors and creators. With a remarkable track record of 11 patents to her name, Cullis has made significant contributions to the field of pharmaceuticals.

Latest Patents

Among her latest patents is the groundbreaking invention "Heteroaryls and uses thereof." This patent provides a compound that acts as an inhibitor of VPS34, offering potential treatments for proliferative, inflammatory, or cardiovascular disorders. The compound's formula I has shown promising results in the realm of pharmaceutical research.

Career Highlights

During her career, Courtney A Cullis has been affiliated with esteemed companies such as Millennium Pharmaceuticals Limited and Abbott Laboratories Corporation. Through her work in these organizations, she has been at the forefront of cutting-edge research and development in the pharmaceutical industry, further solidifying her reputation as a trailblazer in the field.

Collaborations

Cullis has had the privilege of collaborating with talented individuals in her field, including notable coworkers such as Gabriel S Weatherhead and Gang Li. These collaborations have not only enriched her own work but have also led to the creation of innovative solutions that have the potential to positively impact society as a whole.

Conclusion

In conclusion, Courtney A Cullis' outstanding contributions to the field of pharmaceuticals underscore her status as a visionary inventor. Her relentless pursuit of innovation and commitment to addressing critical medical needs serve as a beacon of inspiration for aspiring inventors and researchers worldwide. Courtney A Cullis truly embodies the spirit of innovation and creativity that drives progress in the ever-evolving landscape of invention.

This text is generated by artificial intelligence and may not be accurate.